Ricardo López‐Pérez

1.3k total citations
36 papers, 1.0k citations indexed

About

Ricardo López‐Pérez is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Ricardo López‐Pérez has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Hematology and 6 papers in Genetics. Recurrent topics in Ricardo López‐Pérez's work include Multiple Myeloma Research and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Ricardo López‐Pérez is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Ricardo López‐Pérez collaborates with scholars based in Spain, Argentina and United States. Ricardo López‐Pérez's co-authors include Jesús F. San Miguel, Marcos González, Atanasio Pandiella, Norma C. Gutiérrez, Ramón García‐Sánz, Gema Mateo, Xonia Carvajal‐Vergara, Enrique M. Ocio, Patricia Maiso and Ana Balanzategui and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Ricardo López‐Pérez

35 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ricardo López‐Pérez Spain 18 614 448 222 131 118 36 1.0k
Tetsuya Kurosu Japan 18 473 0.8× 327 0.7× 186 0.8× 97 0.7× 179 1.5× 35 831
Pu Zhang China 13 450 0.7× 304 0.7× 199 0.9× 99 0.8× 145 1.2× 19 876
Nathalie Belhacène France 20 620 1.0× 363 0.8× 242 1.1× 214 1.6× 204 1.7× 26 1.1k
Anuhar Chaturvedi Germany 18 665 1.1× 614 1.4× 127 0.6× 108 0.8× 251 2.1× 33 1.1k
Jung-Hsin Hsu United States 11 800 1.3× 264 0.6× 219 1.0× 94 0.7× 74 0.6× 15 1.0k
L Nagarajan United States 15 497 0.8× 297 0.7× 142 0.6× 79 0.6× 87 0.7× 28 764
Yan Xu China 17 563 0.9× 478 1.1× 436 2.0× 148 1.1× 171 1.4× 111 1.1k
Magali Herrant France 10 637 1.0× 180 0.4× 200 0.9× 179 1.4× 106 0.9× 11 883
S P Treon United States 13 540 0.9× 457 1.0× 447 2.0× 151 1.2× 102 0.9× 20 958
Tiziana Ottone Italy 23 825 1.3× 660 1.5× 159 0.7× 120 0.9× 158 1.3× 63 1.2k

Countries citing papers authored by Ricardo López‐Pérez

Since Specialization
Citations

This map shows the geographic impact of Ricardo López‐Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo López‐Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo López‐Pérez more than expected).

Fields of papers citing papers by Ricardo López‐Pérez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo López‐Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo López‐Pérez. The network helps show where Ricardo López‐Pérez may publish in the future.

Co-authorship network of co-authors of Ricardo López‐Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo López‐Pérez. A scholar is included among the top collaborators of Ricardo López‐Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo López‐Pérez. Ricardo López‐Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ros, Javier, Albert Gil‐Vila, Debayan Datta, et al.. (2025). Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis. Annals of the Rheumatic Diseases. 85(3). 519–533.
2.
Stamatakis, Konstantinos, et al.. (2020). Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer. Frontiers in Pharmacology. 11. 533–533. 28 indexed citations
3.
López‐Pérez, Ricardo, et al.. (2019). Discrepant Antibody Testing Results: Which One to Believe?. Transplantation Proceedings. 51(2). 497–503. 7 indexed citations
4.
López‐Pérez, Ricardo, et al.. (2015). The dilemma of DQ HLA-antibodies. Human Immunology. 76(5). 324–328. 5 indexed citations
5.
Corchado, Juan M., Fernanda Elı́as, Juan Fló, et al.. (2014). Non-Clinical Safety Studies of IMT504, a Unique Non-CpG Oligonucleotide. Nucleic Acid Therapeutics. 24(4). 267–282. 10 indexed citations
6.
González‐González, María, et al.. (2012). Evaluation of chemically modified carrier proteins for developing monoclonal antibodies against a clinically relevant mutation of cKIT. Journal of Immunological Methods. 384(1-2). 171–176. 5 indexed citations
7.
Díaz‐Rodríguez, Elena, Stela Álvarez-Fernández, Xi Chen, et al.. (2011). Deficient Spindle Assembly Checkpoint in Multiple Myeloma. PLoS ONE. 6(11). e27583–e27583. 35 indexed citations
8.
Corchado, Juan M., Fernanda Elı́as, Juan Fló, et al.. (2009). A High Dose of IMT504, the PyNTTTTGT Prototype Immunostimulatory Oligonucleotide, Does Not Alter Embryonic Development in Rats. Oligonucleotides. 20(1). 33–36. 9 indexed citations
9.
Mollinedo, Faustino, Ricardo López‐Pérez, & Consuelo Gajate. (2008). Differential gene expression patterns coupled to commitment and acquisition of phenotypic hallmarks during neutrophil differentiation of human leukaemia HL-60 cells. Gene. 419(1-2). 16–26. 36 indexed citations
10.
Aouacheria, Abdel, Vincent Navratil, Ricardo López‐Pérez, et al.. (2007). In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions. BMC Genomics. 8(1). 2–2. 19 indexed citations
11.
Maiso, Patricia, Xonia Carvajal‐Vergara, Enrique M. Ocio, et al.. (2006). The Histone Deacetylase Inhibitor LBH589 Is a Potent Antimyeloma Agent that Overcomes Drug Resistance. Cancer Research. 66(11). 5781–5789. 193 indexed citations
12.
13.
14.
Carvajal‐Vergara, Xonia, Soraya Tabera, Juan Carlos Montero, et al.. (2005). Multifunctional role of Erk5 in multiple myeloma. Blood. 105(11). 4492–4499. 75 indexed citations
15.
González, David, Marcos González, M. Eva Alonso, et al.. (2003). Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR. Leukemia. 17(6). 1051–1057. 22 indexed citations
16.
Mateos, María‐Victoria, Ramón García‐Sánz, Ricardo López‐Pérez, et al.. (2002). Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival. British Journal of Haematology. 118(4). 1034–1040. 63 indexed citations
17.
Mateos, María‐Victoria, Ramón García‐Sánz, Ricardo López‐Pérez, et al.. (2001). p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies. The Hematology Journal. 2(3). 146–149. 23 indexed citations
18.
Mateos, María‐Victoria, Marcos González, Ana Balanzategui, et al.. (2000). Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection. Clinical Biochemistry. 33(5). 415–418. 4 indexed citations
19.
López‐Pérez, Ricardo, Ramón García‐Sánz, David González, et al.. (2000). The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Leukemia. 14(8). 1493–1499. 17 indexed citations
20.
López‐Pérez, Ricardo, O. Grau, & María T. Franze‐Fernández. (1986). Effect of actinomycin D on arenavirus growth and estimation of the generation time for a virus particle. Virus Research. 5(2-3). 213–220. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuya Kurosu Breakdown of academic impact, for papers by Pu Zhang Breakdown of academic impact, for papers by Nathalie Belhacène Breakdown of academic impact, for papers by Anuhar Chaturvedi Breakdown of academic impact, for papers by Jung-Hsin Hsu Breakdown of academic impact, for papers by L Nagarajan Breakdown of academic impact, for papers by Yan Xu Breakdown of academic impact, for papers by Magali Herrant Breakdown of academic impact, for papers by S P Treon Breakdown of academic impact, for papers by Tiziana Ottone
Rankless by CCL
2026